Demand for refund on dud drugs

Professional Adviser
clock •

Charities have petitioned a pharmaceutical firm to cut the cost of a drug that can treat bone marrow...

Charities have petitioned a pharmaceutical firm to cut the cost of a drug that can treat bone marrow cancer, so it can be used by the NHS in England and Wales. Myeloma UK, MacMillan Cancer Support and Leukaemia CARE have asked the manufacturer, Janssen-Cilag to adopt a similar stance on Revlimid to that taken with Velcade, for which refunds are given if it is ineffective on patients. The charities are also asking for the price of the drug to be reduced with a discount. Revlimid, which costs around £4,500 a month per patient, can extend the lives of myeloma patients for up to three years...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on uncategorised

Professional Adviser named Retail & Wholesale Publication of the Year

Professional Adviser named Retail & Wholesale Publication of the Year

Aviva Investors Sustainability Media Awards

Professional Adviser
clock 09 November 2026 • 1 min read
PA Awards 2027: Last chance - entries close at midnight tonight

PA Awards 2027: Last chance - entries close at midnight tonight

The 22nd Professional Adviser Awards will take place in London next March

Professional Adviser
clock 18 September 2026 • 1 min read
Multi-Asset and MPS Roadshow: Last chance to join PA in Harrogate or Warrington

Multi-Asset and MPS Roadshow: Last chance to join PA in Harrogate or Warrington

Hear from Aberdeen, Aviva Investors, Clever, Downing, Fidelity, Quilter Cheviot, Rathbones

Professional Adviser
clock 08 September 2026 • 1 min read